Determining severity subtypes of depression with a self-report questionnaire

Area of Science:

• Psychiatry
• Clinical Psychology
• Health Services Research

Background:

• Recent American Psychiatric Association guidelines emphasize considering symptom severity for major depressive disorder (MDD) treatment selection.
• The Rhode Island Methods to Improve Diagnostic Assessment and Services (MIDAS) project investigated correlates of depression severity classification.
• Accurate severity assessment is vital for tailoring effective MDD interventions.

Purpose of the Study:

• To examine the correlates of depression severity classification using a self-report measure in psychiatric outpatients.
• To validate the use of the Clinically Useful Depression Outcome Scale (CUDOS) for subtyping depression severity.
• To assess the relationship between depression severity, psychosocial morbidity, and treatment response.

Main Methods:

• Two studies were conducted with psychiatric outpatients diagnosed with depression.
• Study 1: 470 outpatients completed the CUDOS and psychosocial morbidity measures.
• Study 2: 112 outpatients completed the CUDOS and were assessed with the Hamilton Depression Rating Scale (HDRS) at baseline and 3 months.

Main Results:

• Moderately and severely depressed patients reported significantly higher psychosocial morbidity than mildly depressed patients.
• Greater depression severity was associated with reduced rates of treatment response and remission.
• The CUDOS demonstrated validity in differentiating depression severity levels.

Conclusions:

• Self-report depression questionnaires, like the CUDOS, can reliably subtype patients based on depression severity.
• Severity classification is linked to psychosocial functioning and treatment outcomes in major depressive disorder.
• These findings support the use of self-report tools for guiding MDD treatment selection.